The effect of novel promoter variants in MATE1 and MATE2 on the pharmacokinetics and pharmacodynamics of metformin

Interindividual variation in response to metformin, first-line therapy for type 2 diabetes, is substantial. Given that transporters are determinants of metformin pharmacokinetics, we examined the effects of promoter variants in both multidrug and toxin extrusion protein 1 (MATE1) (g.−66T→C, rs225228...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Stocker, Sophie L., Morrissey, Kari M., Yee, Sook Wah, Castro, Richard A., Xu, Lu, Dahlin, Amber, Ramirez, Andrea H., Roden, Dan M., Wilke, Russ A., McCarty, Cathy A., Davis, Robert L., Brett, Claire M., Giacomini, Kathleen M.
Format: Artigo
Jezik:Inglês
Izdano: 2012
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3671611/
https://ncbi.nlm.nih.gov/pubmed/23267855
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/clpt.2012.210
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items